Page 2 - Caredx Inc News Today

Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]

CareDx, Inc. – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare...

Late-Breaking Abstract Presentation to Showcase Results from SHORE Registry Highlighting Benefits of Surveillance with HeartCare ...

Joydeep Goswami to serve as advisor through June 30 Illumina reaffirms Q1 2024 and full-year 2024 financial guidance SAN DIEGO, April 9, 2024 /PRNewswire/ -- Illumina, Inc. , a global leader in DNA...

CareDx Inc. announced that Bryan Riggsbee joins CareDx?s Board of Directors, effective March 11, 2024. Riggsbee previously served as Chief Financial Officer at Myriad Genetics, where he made...

CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.

Full Year Revenue Exceeds Guidance; Patent Litigation Impacts Net Loss

CareDx, Inc. – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare...

CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...

Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The